Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

Even if the FDA grants full approval of the Alzheimer’s treatment Leqembi, the rollout will take years.

22,709
Like
Save

Comments

Comments are disabled for this post.

Forex SearchClose
Copyright © RichFXM.com. Back to Forex Search